HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qunying Mao Selected Research

Infections

1/2022How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review.
12/2021Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains.
1/2019A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis.
11/2018A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5.
6/2018A cross-sectional seroepidemiology study of EV-D68 in China.
1/2018A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies.
1/2017Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5.
1/2017A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation.
10/2016A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6.
1/2015Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qunying Mao Research Topics

Disease

12Infections
01/2022 - 01/2014
6Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease)
01/2019 - 11/2012
4COVID-19
01/2022 - 01/2021
2Communicable Diseases (Infectious Diseases)
04/2022 - 07/2016
1Porcine Reproductive and Respiratory Syndrome (PRRS)
12/2022
1Human Influenza (Influenza)
04/2022
1Virus Diseases (Viral Diseases)
01/2022
1Breakthrough Infections
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Hepatitis E
01/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2019
1Exanthema (Rash)
10/2016
1Myocarditis (Carditis)
07/2016
1Encephalitis (Encephalitis, Rasmussen)
07/2016
1Herpangina
02/2014
1Fever (Fevers)
02/2014
1Poliomyelitis (Polio)
01/2013

Drug/Important Bio-Agent (IBA)

20VaccinesIBA
12/2022 - 11/2012
7Neutralizing AntibodiesIBA
01/2022 - 01/2014
3Antiviral Agents (Antivirals)IBA
10/2016 - 01/2014
2ZF2001 COVID-19 vaccineIBA
12/2022 - 01/2022
2Pattern Recognition ReceptorsIBA
12/2022 - 01/2022
2antineoplaston A10 (A 10)IBA
01/2019 - 01/2017
2poly-N-4-vinylbenzyllactonamideIBA
01/2018 - 01/2013
1Proteins (Proteins, Gene)FDA Link
01/2022
1Protein Subunits (Protein Subunit)IBA
01/2022
1Biological ProductsIBA
01/2020
1LuciferasesIBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2017
1AntibodiesIBA
01/2017
1AntigensIBA
10/2016
1Indicators and Reagents (Reagents)IBA
10/2016
1Therapeutic UsesIBA
10/2016
1Combined VaccinesIBA
01/2014
1Immune Sera (Antisera)IBA
01/2013